Catalog NumberYM00174
CategoryADCs
Description
Anti-KAAG1 (ADCT-901-MMAE) is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1. It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer.
Synonyms
ADCT-901
Molecular Weight
1452.80
Purity
98% Min.
Storage
Store at -20°C
Endotoxin Levels
<1 EU/mg
Form
Powder
Formulation
100 mM Pro-Ac, 20 mM Arg, pH 5.0
Impurity Content
2% Max.
Protein Concentration
5.629 mg/mL
Size
1 mg